![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 31/4709 | (2006.01) |
A61K 31/4709 | (2013.01) | ||
A61P 35/00 | (2006.01) | ||
A61P 35/00 | (2018.01) |
(11) | Patento numeris | 3542800 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 19172562.1 |
Europos patento paraiškos padavimo data | 2018-02-21 | |
(97) | Europos patento paraiškos paskelbimo data | 2019-09-25 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2022-06-01 |
(46) | Apibrėžties vertimo paskelbimo data |
(30) | Numeris | Data | Šalis |
201762461602 P | 2017-02-21 | US | |
201762507749 P | 2017-05-17 | US | |
201762519819 P | 2017-06-14 | US | |
201715820157 | 2017-11-21 | US | |
201715820012 | 2017-11-21 | US | |
201762596653 P | 2017-12-08 | US |
(72) |
GUALBERTO, Antonio , US
SCHOLZ, Catherine Rose , US
|
(73) |
Kura Oncology, Inc. ,
12730 High Bluff Drive, Suite 400, San Diego, CA 92130,
US
|
(54) | METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS |
METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS |